2 startups from the iPEPS-ICM incubator won the Soft Landing Boston Program

Event Published May 4 2017
Open / close summary

Soft Landing Boston is a program for medtech and eHealth companies (medical devices, wearables or diagnostics products). Designed by Medicen Paris Region, Bpifrance, French Tech Hub, Mednest and MassMEDIC, this programis aimed at helping companies to develop their innovative products in North America. For this second edition, eight companies have been selected to attend an intensive program during the MassMEDIC event in Boston in May.

A bilateral expert judging panel composed of healthcare experts, investors and representatives of innovation organizations from Paris and Boston, such as Brown Rudnick, Acceleration International and Bpifrance, selected 8 startups amongst 24 to participate to the Soft Landing Boston Program.

These eight companies were selected based on their innovative solutions, team expertise and business potential for the US market. BioSerenity and Neurallys, two startups from the iPEPS-ICM incubator, are among this final selection.

BioSerenity is a company specialized in developing mobile neurology diagnostic devices. Their offer, The Neuronaute, uses smart clothing to allow monitoring and diagnosis of epilepsy. This solution simplifies monitoring for healthcare professionals and allows for long term in or outpatient monitoring.
Neurallys aims to develop medical devices in the field of neurology and neurosurgery. Neurallys develops a smart sensor offering continuous measurement of intracranial pressure for patients living with hydrocephalus to diagnose valve dysfunction, increasing patient comfort and preventing exploratory surgeries for people who have a shunt.

The winners will attend an intensive five-day program in Boston in early May. This
Includes workshops focusing on reimbursement, healthcare economics and fundraising strategy, and qualified mentoring sessions as well as further Pitching opportunities. They will also benefit from increased visibility in the US market.

“We are delighted to be part of this high-level program in Boston, organized for the eight winners selected for the Soft Landing scheme. This initiative perfectly matches the dynamic of international immersion of startups that Bpifrance wishes to strenghten.” said Evelyne Scuto Gaillard, director of development and innovation support at Bpifrance.

Following the one-week immersion program, two companies will be selected and will have the opportunity to pitch at the MassMEDIC medtech showcase in October 2017.